Physician profile
James D Lilly
NPI 1003819350
$6,222.38
in general payments reported to CMS, 2019-2025
31 companies · $1,498 in 2025
The $1,498 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $144 · 2021: $682 · 2022: $1,191 · 2023: $949 · 2024: $1,619 · 2025: $1,498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,065.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,542.08 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $545.51 | 2022-2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $459.86 | 2021-2025 | Xifaxan, Trulance, Plenvu |
| Pfizer INC. | $305.06 | 2021-2025 | |
| Celgene Corporation | $291.83 | 2021-2022 | |
| Genzyme Corporation | $285.34 | 2022-2025 | |
| Ardelyx, INC. | $252.36 | 2023-2025 | Ibsrela |
| Janssen Biotech, INC. | $223.74 | 2022-2025 | Stelara, Tremfya, Simponi Aria |
| Gilead Sciences, INC. | $191.62 | 2019-2025 | |
| Ironwood Pharmaceuticals, INC | $167.44 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $161.50 | 2024-2025 | Dupixent |
| Madrigal Pharmaceuticals | $104.90 | 2024-2025 | Rezdiffra, Resmetirom |
| Ipsen Biopharmaceuticals, INC | $89.31 | 2024-2025 | Iqirvo |
| Phathom Pharmaceuticals, INC. | $83.26 | 2024-2025 | Voquezna |
| Ferring Pharmaceuticals INC. | $74.08 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $69.80 | 2020-2023 | Dificid |
| Aimmune Therapeutics, INC. | $46.88 | 2025 | Vowst |
| Biocon Biologics INC | $36.01 | 2025 | Yesintek |
| Redhill Biopharma INC. | $32.69 | 2021-2022 | |
| Intercept Pharmaceuticals, INC. | $32.22 | 2023-2024 | Ocaliva |
| Lilly USA, LLC | $31.80 | 2025 | Omvoh |
| Novo Nordisk INC | $31.73 | 2025 | Wegovy |
| Qol Medical, LLC | $29.41 | 2019-2020 | |
| Organon LLC | $29.40 | 2024-2025 | Hadlima |
| Evoke Pharma, INC. | $23.32 | 2021 | |
| Ucb, INC. | $19.55 | 2019 | |
| Fujifilm Healthcare Americas Corporation | $18.42 | 2024 | Utaswako Afp-L3 |
| Alexion Pharmaceuticals, INC. | $16.79 | 2022 | |
| Baxter Healthcare | $14.43 | 2023 | |
| Braintree Laboratories, INC. | $12.04 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$17,889.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.